Banca Mediolanum SpA
MIL:BMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Banca Mediolanum SpA
MIL:BMED
|
IT |
|
S
|
SillaJen Inc
KOSDAQ:215600
|
KR |
|
C
|
Co2 Capsol AS
OSE:CAPSL
|
NO |
|
American Defense Systems Inc
OTC:ADFS
|
US |
|
S
|
Sahamitr Pressure Container PCL
SET:SMPC
|
TH |
|
Hour Glass Ltd
SGX:AGS
|
SG |
|
Aritzia Inc
TSX:ATZ
|
CA |
|
Aecon Group Inc
TSX:ARE
|
CA |
|
Silver Elephant Mining Corp
TSX:ELEF
|
CA |
|
Life360 Inc
NASDAQ:LIF
|
US |
Wall Street
Price Targets
BMED Price Targets Summary
Banca Mediolanum SpA
According to Wall Street analysts, the average 1-year price target for
BMED
is 21.9 EUR
with a low forecast of 20.5 EUR and a high forecast of 23.94 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BMED's stock price target?
Price Target
21.9
EUR
According to Wall Street analysts, the average 1-year price target for
BMED
is 21.9 EUR
with a low forecast of 20.5 EUR and a high forecast of 23.94 EUR.
What is Banca Mediolanum SpA's Net Income forecast?
Projected CAGR
-1%
For the last 14 years the
compound annual growth rate for
Banca Mediolanum SpA's net income is
-14%.
The projected
CAGR
for the next 3 years is
-1%.
